TapewireFind a company

person · Reporting owner

BERGER DAVID B

Disclosed activity across 1 company

Tapewire entity
107893
SEC CIK
0001422126

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
TANDEM DIABETES CARE INCTNDM · Entity 4682EVP & Chief Operating OfficerNovember 27, 2023November 29, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

TANDEM DIABETES CARE INC

Report date November 27, 2023 · Filed November 29, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect6,338 Ending reported balance After 2023-11-27 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2023-11-27 · Exercise / conversion · Acquired 406 · Balance 6,479

Row 2 · 2023-11-27 · Tax withholding · Disposed 141 · Balance 6,338

F1: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect813 Reported balance After 2023-11-27 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2023-11-27 · Exercise / conversion · Disposed 406 · Balance 813

F3: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Common StockSEC Table I · non-derivativeIndirectBerger Family Trust242 Reported balance Holding disclosure · report date 2023-11-27 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 242

F2: The securities are held by the Berger Family Trust dated April 16, 2008.

Filing footnotes · ownership attribution and instrument terms

F1: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

F2: The securities are held by the Berger Family Trust dated April 16, 2008.

F3: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 27, 2023 Filed Nov 29, 2023 21:10 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000249 · wk-form4_1701292197.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 813

Underlying: Common Stock · 406 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:10 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 141 $19.47 $2,745.27
Disclosure

SEC source: 0001438133-23-000249 · wk-form4_1701292197.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,338

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:10 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000249 · wk-form4_1701292197.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,479

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000227 · wk-form4_1700255384.xml · derivative · entry 7

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,846

Underlying: Common Stock · 474 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F7 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F7 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000227 · wk-form4_1700255384.xml · derivative · entry 6

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 975

Underlying: Common Stock · 162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 164 $18.20 $2,984.80
Disclosure

SEC source: 0001438133-23-000227 · wk-form4_1700255384.xml · nonDerivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,073

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000227 · wk-form4_1700255384.xml · nonDerivative · entry 3

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,237

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 57 $18.20 $1,037.40
Disclosure

SEC source: 0001438133-23-000227 · wk-form4_1700255384.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,763

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000227 · wk-form4_1700255384.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,820

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 28, 2023 Filed Aug 30, 2023 20:07 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 407 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000187 · wk-form4_1693426057.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,219

Underlying: Common Stock · 407 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
August 28, 2023 Filed Aug 30, 2023 20:07 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 141 $27.06 $3,815.46
Disclosure

SEC source: 0001438133-23-000187 · wk-form4_1693426057.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,658

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 28, 2023 Filed Aug 30, 2023 20:07 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 407 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000187 · wk-form4_1693426057.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,799

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 20:11 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000159 · wk-form4_1692303082.xml · derivative · entry 7

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,320

Underlying: Common Stock · 474 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan, as amended, and the agreements related thereto.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F7 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F7 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 20:11 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000159 · wk-form4_1692303082.xml · derivative · entry 6

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,137

Underlying: Common Stock · 162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 20:11 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 164 $28.88 $4,736.32
Disclosure

SEC source: 0001438133-23-000159 · wk-form4_1692303082.xml · nonDerivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,392

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 20:11 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000159 · wk-form4_1692303082.xml · nonDerivative · entry 3

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,556

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 20:11 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 57 $28.88 $1,646.16
Disclosure

SEC source: 0001438133-23-000159 · wk-form4_1692303082.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,082

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 20:11 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000159 · wk-form4_1692303082.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,139

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 30, 2023 Filed May 31, 2023 01:30 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000126 · wf-form4_168549660512659.xml · derivative · entry 6

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,626

Underlying: Common Stock · 406 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care,Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F8 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F8 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 30, 2023 Filed May 31, 2023 01:30 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 141 $26.57 $3,746.37
Disclosure

SEC source: 0001438133-23-000126 · wf-form4_168549660512659.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,977

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 30, 2023 Filed May 31, 2023 01:30 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000126 · wf-form4_168549660512659.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,118

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 25, 2023 Filed May 31, 2023 01:30 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantPSU 2023 05 25 · Derivative 8,883 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000126 · wf-form4_168549660512659.xml · derivative · entry 5

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,883

Underlying: Common Stock · 8,883 shares

Expires not disclosed

F3 · security: Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).

F6 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2025 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

F6 · derivative.exercise_date: Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2025 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

F6 · derivative.expiration_date: Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2025 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

Read SEC document
May 25, 2023 Filed May 31, 2023 01:30 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantRSU 2023 05 25 · Derivative 18,037 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000126 · wf-form4_168549660512659.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,037

Underlying: Common Stock · 18,037 shares

Expires not disclosed

F3 · security: Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F5 · derivative.exercise_date: RSU vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

F5 · derivative.expiration_date: RSU vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:18 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 1,897 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000086 · wf-form4_168436187586847.xml · derivative · entry 7

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,794

Underlying: Common Stock · 1,897 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F5 · derivative.exercise_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:18 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000086 · wf-form4_168436187586847.xml · derivative · entry 6

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,299

Underlying: Common Stock · 163 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:18 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 656 $32.13 $21,077.28
Disclosure

SEC source: 0001438133-23-000086 · wf-form4_168436187586847.xml · nonDerivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,712

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:18 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 1,897 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000086 · wf-form4_168436187586847.xml · nonDerivative · entry 3

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,368

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:18 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 57 $32.13 $1,831.41
Disclosure

SEC source: 0001438133-23-000086 · wf-form4_168436187586847.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,471

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:18 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000086 · wf-form4_168436187586847.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,528

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 23:41 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 10,000 $18.86 Strike: $18.86 $188,600.00
Disclosure

SEC source: 0001438133-23-000050 · wf-form4_167823247447992.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 23:41 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 10,000 $41.19 $411,884.00
Disclosure

SEC source: 0001438133-23-000050 · wf-form4_167823247447992.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,365

F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $41.16 to $41.24. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 23:41 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 10,000 $18.86 $188,600.00
Disclosure

SEC source: 0001438133-23-000050 · wf-form4_167823247447992.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,365

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 22:35 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 407 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000036 · wf-form4_167771008702883.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,032

Underlying: Common Stock · 407 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 22:35 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 166 $35.87 $5,954.42
Disclosure

SEC source: 0001438133-23-000036 · wf-form4_167771008702883.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,365

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 22:35 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 407 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000036 · wf-form4_167771008702883.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 21:33 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000010 · wf-form4_167666960089426.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,462

Underlying: Common Stock · 162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 21:33 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 67 $43.11 $2,888.37
Disclosure

SEC source: 0001438133-23-000010 · wf-form4_167666960089426.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,124

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 21:33 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000010 · wf-form4_167666960089426.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,191

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 16, 2022 Filed Dec 19, 2022 22:37 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 10,000 $18.86 Strike: $18.86 $188,600.00
Disclosure

SEC source: 0001438133-22-000261 · wf-form4_167148943140963.xml · derivative · entry 7

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
December 16, 2022 Filed Dec 19, 2022 22:37 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 10,000 $40.25 $402,500.00
Disclosure

SEC source: 0001438133-22-000261 · wf-form4_167148943140963.xml · nonDerivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,029

F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $40.20 to $40.37. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
December 16, 2022 Filed Dec 19, 2022 22:37 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 10,000 $18.86 $188,600.00
Disclosure

SEC source: 0001438133-22-000261 · wf-form4_167148943140963.xml · nonDerivative · entry 3

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,029

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 22:37 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 15,000 $18.86 Strike: $18.86 $282,900.00
Disclosure

SEC source: 0001438133-22-000261 · wf-form4_167148943140963.xml · derivative · entry 6

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 15,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 22:37 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 15,000 $40.32 $604,800.00
Disclosure

SEC source: 0001438133-22-000261 · wf-form4_167148943140963.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,029

F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $40.20 to $40.50. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 22:37 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 15,000 $18.86 $282,900.00
Disclosure

SEC source: 0001438133-22-000261 · wf-form4_167148943140963.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,029

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 28, 2022 Filed Nov 30, 2022 21:22 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000241 · wf-form4_166984334543413.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,439

Underlying: Common Stock · 406 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 28, 2022 Filed Nov 30, 2022 21:22 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 202 $39.54 $7,987.08
Disclosure

SEC source: 0001438133-22-000241 · wf-form4_166984334543413.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,029

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 28, 2022 Filed Nov 30, 2022 21:22 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 406 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000241 · wf-form4_166984334543413.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,231

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2022 Filed Nov 17, 2022 23:36 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000223 · wf-form4_166872818692809.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,624

Underlying: Common Stock · 163 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2022 Filed Nov 17, 2022 23:36 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 81 $42.27 $3,423.87
Disclosure

SEC source: 0001438133-22-000223 · wf-form4_166872818692809.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,825

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2022 Filed Nov 17, 2022 23:36 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000223 · wf-form4_166872818692809.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,906

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.